Adjunctive raloxifene improves outcomes in women with refractory schizophrenia
Adjunctive raloxifene enhances results in women with refractory schizophrenia Raloxifene hydrochloride, a selective estrogen receptor modulator with combined agonist and antagonist activity, minimized disease seriousness and increased possibility of clinical response in females with treatment-resistant schizophrenia, according to recent ... http://www.youtube.com/watch?v= See all stories on this topic Evaluation of Worldwide Video Telemedicine Market to [...]